Allarity Therapeutics, Inc. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
Allarity Therapeutics, Inc. (ALLR) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of $29.66 million as of 2021-09-30, per its 10-Q/A filed 2022-05-17.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2022-05-17
- 2021-09-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $29.66M; Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest as first filed $32.77M.
- 2020-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $24.44M; Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest as first filed $26.85M.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest as first filed |
|---|---|---|
| 2021-09-30 | $29.66M 10-Q/A · filed 2022-05-17 | $32.77M 10-Q · filed 2021-11-23 |
| 2020-12-31 | $24.44M 10-Q/A · filed 2022-05-17 | $26.85M 10-Q · filed 2021-11-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |